Somewhat Favorable Press Coverage Somewhat Unlikely to Affect Metabolix (YTEN) Share Price

News headlines about Metabolix (NASDAQ:YTEN) have trended somewhat positive recently, Accern Sentiment reports. Accern ranks the sentiment of media coverage by analyzing more than 20 million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Metabolix earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news articles about the specialty chemicals company an impact score of 45.2927691355909 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the near future.

Metabolix (NASDAQ:YTEN) traded up 1.10% during midday trading on Wednesday, hitting $3.68. 1,296 shares of the stock traded hands. Metabolix has a 52 week low of $0.25 and a 52 week high of $9.03. The stock’s 50-day moving average price is $2.73 and its 200-day moving average price is $2.24. The stock’s market capitalization is $12.71 million.

Metabolix (NASDAQ:YTEN) last issued its quarterly earnings results on Thursday, August 10th. The specialty chemicals company reported ($0.96) earnings per share (EPS) for the quarter. The business had revenue of $0.29 million during the quarter. Metabolix had a negative return on equity of 145.04% and a negative net margin of 190.57%.

ILLEGAL ACTIVITY WARNING: This report was first reported by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another website, it was illegally copied and reposted in violation of US & international trademark and copyright laws. The original version of this report can be accessed at

About Metabolix

Yield10 Bioscience, Inc, formerly Metabolix, Inc, is an agricultural bioscience company. The Company is focused on developing disruptive technologies for step-change improvements in crop yield for food and feed crops to enhance global food security. By working on new approaches to improve fundamental elements of plant photosynthetic efficiency and optimizing carbon metabolism to direct more carbon to seed production, the Company is advancing several yield traits it has developed in crops, such as Camelina, canola, soybean and corn.

Insider Buying and Selling by Quarter for Metabolix (NASDAQ:YTEN)

Receive News & Ratings for Metabolix Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Metabolix Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply